GLG Life Tech的2025年第3季度收入下降36%至210万美元,原因是斯捷维亚价格和数量降低,但净收入在出售了Runhai的单位后增加到15.4亿美元。 GLG Life Tech's Q3 2025 revenue fell 36% to $2.1M due to lower stevia prices and volumes, but net income rose year-to-date to $15.4M after selling its Runhai unit.

GLG Life Tech报称,2025年Q3收入下降36%,降至210万美元,原因是竞争性斯捷维亚市场的价格和销售量降低,九个月的收入下降22%,降至820万美元。 GLG Life Tech reported a 36% revenue drop in Q3 2025 to $2.1 million, driven by lower prices and sales volumes in the competitive stevia market, with nine-month revenue down 22% to $8.2 million. 该公司在问题3中将SG&A开支削减23%,迄今为止每年削减34%。 The company cut SG&A expenses by 23% in Q3 and 34% year-to-date. 持续业务的净损失在问题3中上升到520万美元,而前九个月的净收入从1 150万美元的损失增加到1 540万美元,这主要是由于最终处置了前Runhai子公司。 Net loss from continuing operations rose to $5.2 million in Q3, while net income for the first nine months reached $15.4 million, up from a $11.5 million loss, largely due to the final disposal of its former Runhai subsidiary. 股东核准以名义数额将Runhai转让给第三方,从而改进了资产负债表并降低了中国的监管风险。 Shareholders approved the transfer of Runhai to a third party for a nominal amount, improving the balance sheet and reducing regulatory risk in China. 五位董事都是在压倒多数的支持下连选连任的,该公司继续与青岛洪丰元签订长期制造协议。 All five directors were re-elected with overwhelming support, and the company continues a long-term manufacturing agreement with Qingdao Honghongyuan.